UBS Group’s Reviva Pharmaceuticals Holdings, Inc. Warrants RVPHW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,734
| Closed | -$612 | – | 9197 |
|
|
2024
Q4 | $612 | Buy |
3,734
+3,068
| +461% | +$503 | ﹤0.01% | 8162 |
|
|
2024
Q3 | $90 | Sell |
666
-3,995
| -86% | -$540 | ﹤0.01% | 7952 |
|
|
2024
Q2 | $1.26K | Buy |
4,661
+2,279
| +96% | +$615 | ﹤0.01% | 7445 |
|
|
2024
Q1 | $1.5K | Buy |
+2,382
| New | +$1.5K | ﹤0.01% | 6948 |
|
|
2023
Q2 | – | Sell |
-1,670
| Closed | -$1.67K | – | 8314 |
|
|
2023
Q1 | $1.67K | Buy |
+1,670
| New | +$1.67K | ﹤0.01% | 7578 |
|
|
2022
Q4 | – | Sell |
-6,901
| Closed | -$1K | – | 9763 |
|
|
2022
Q3 | $1K | Buy |
6,901
+6,470
| +1,501% | +$938 | ﹤0.01% | 8911 |
|
|
2022
Q2 | $0 | Buy |
+431
| New | – | ﹤0.01% | 9659 |
|
|
2021
Q4 | – | Sell |
-234
| Closed | – | – | 9357 |
|
|
2021
Q3 | $0 | Buy |
234
+64
| +38% | – | ﹤0.01% | 8710 |
|
|
2021
Q2 | $0 | Sell |
170
-12,287
| -99% | – | ﹤0.01% | 8541 |
|
|
2021
Q1 | $6K | Buy |
12,457
+11,393
| +1,071% | +$5.49K | ﹤0.01% | 7211 |
|
|
2020
Q4 | $1K | Sell |
1,064
-11,305
| -91% | -$10.6K | ﹤0.01% | 7212 |
|
|
2020
Q3 | $6K | Buy |
12,369
+5,870
| +90% | +$2.85K | ﹤0.01% | 6349 |
|
|
2020
Q2 | $3K | Buy |
+6,499
| New | +$3K | ﹤0.01% | 6695 |
|